Abnormal uterine bleeding in girls: tips and tools

M.S. Selikhova1, E.S. Zvereva2 1Volgograd State Medical University, Volgograd, Russian Federation 2Emergency Clinical Hospital No. 7, Volgograd, Russian Federation Pubertal abnormal uterine bleeding (AUB) is the leading cause of visits to health care provider during adolescent period. The paper describes clinical course of pubertal AUB and the assessment of their severity and hemostasis. The importance of stress factors and somatic comorbidities is discussed. Data on anemia severity in girls with AUB to assess blood loss and treatment efficacy are addressed. Ultrasound reveals ovarian cysts in 10% and endometrial hyperplasia in 17% of these girls. In girls with comorbidities (including obesity), symptomatic hemostasis is associated with high risks of recurrent AUB. When selecting antianemia drugs, the lack of toxicity, good tolerability, and availability of both parenteral and peroral formulations used in various clinical situations should be considered. After homeostasis was achieved, hormonal and antianemic treatment is continued for 3 months. Keywords: abnormal uterine bleeding, pubertal period, hemostasis, anemia, iron deficiency, iron supplements. For citation: Selikhova M.S., Zvereva E.S. Abnormal uterine bleeding in girls: tips and tools. Russian Journal of Woman and Child Health. 2019;2(4):351–354. <br

Effect of combined oral contraceptives conaining drospirenone + ethinylestradiol on the mammary gland condition in women of reproductive age

Drospirenone, as a part of combined oral contraceptives, has an antiproliferative effect on hyperplastic processes in the organs of the female reproductive system. Individual selection of COCs taking into account the dose and properties of the gestagenic and estrogenic components allows, with contraceptive and non-contraceptive purposes, to prescribe it to women of reproductive age. Intake of COC containing drospirenone + ethinyl estradiol is not associated with impaired drug tolerance due to complaints of soreness and breast engorgement in the first 3 months. 6 months of COCs containing drospirenone + ethinyl estradiol are significantly associated with a decrease in the frequency of clinical and US-signs of dyshormonal dysplasia of the breast. © 2018 Stavropol State Medical University. All rights reserved

Effect of combined oral contraceptives conaining drospirenone + ethinylestradiol on the mammary gland condition in women of reproductive age

Drospirenone, as a part of combined oral contraceptives, has an antiproliferative effect on hyperplastic processes in the organs of the female reproductive system. Individual selection of COCs taking into account the dose and properties of the gestagenic and estrogenic components allows, with contraceptive and non-contraceptive purposes, to prescribe it to women of reproductive age. Intake of COC containing drospirenone + ethinyl estradiol is not associated with impaired drug tolerance due to complaints of soreness and breast engorgement in the first 3 months. 6 months of COCs containing drospirenone + ethinyl estradiol are significantly associated with a decrease in the frequency of clinical and US-signs of dyshormonal dysplasia of the breast. © 2018 Stavropol State Medical University. All rights reserved